ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

167
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
•04 Feb 2019 00:00

Asia HY Monthly - Agency Ratings For Asian Issuers - Lucror Analytics

In this month’s “In-Focus” section, we look at agency ratings for Asian issuers. The Asia Monthly focuses on providing updates on recent events,...

Logo
250 Views
Share
•25 Jan 2019 00:00

Asia HY Trade Recommendations - January 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for January includes a summary of our recommendations, as well as our high-conviction ideas. We also...

Logo
187 Views
Share
bearish•Aurobindo Pharma
•01 Jan 2019 22:29

India Generic Drugs: Antitrust Suit Could Cost Billions

This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and...

Share
bearish•MSCI World Index
•15 Nov 2018 21:39

Global Markets Outlook: Maintain Defensive Posture

Our outlook for global equity markets remains cautious and we expect additional weakness and consolidation, notwithstanding shorter-term...

Logo
688 Views
Share
•05 Nov 2018 22:59

EM Strategy: Brazil Breaking Out, EM Energy Remains Attractive

While the MSCI EM index remains in a well-defined downtrend, and we continue to recommend selectivity, we highlight several investable themes and...

Logo
622 Views
Share
x